Explanation: "This measure assesses the percentage of adult diabetes patients aged 18-75 years receiving one or more A1c test(s) per year."

Why is this important?: "Intensive therapy of glycosylated hemoglobin (A1c) reduces the risk of microvascular complications. American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE) recommends that a glycosylated hemoglobin be performed during an initial assessment and during follow-up assessments, which should occur at no longer than three-month intervals."  

 

Taken from the National Quality Measures Clearinghouse

http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=4066